Table 1.
Indication | N (%) |
---|---|
Hepatitis C | 65 (64) |
Elevated liver enzymes | 11 (10.9) |
Nonalcoholic fatty liver disease | 8 (7.9) |
Hepatitis B | 8 (7.9) |
Autoimmune hepatitis | 4 (4) |
Drug toxicity | 2 (2) |
Primary biliary cirrhosis | 1 (1) |
Primary sclerosing cholangitis | 1 (1) |